The Problem: Brain Tumor Surgery Is Priced Beyond Reach for Many Patients

According to the National Brain Tumor Society, approximately 94,000 Americans will receive a primary brain tumor diagnosis in 2025. Gliomas — tumors arising from glial cells — account for about 30% of all brain tumors and 80% of malignant ones. A diagnosis of high-grade glioma carries a median survival of 14 to 16 months without aggressive intervention. Surgery remains the cornerstone of treatment, followed by radiation and temozolomide chemotherapy.

The financial weight of that protocol is staggering. A 2023 analysis published in Neuro-Oncology Practice found that the total cost of care for glioblastoma in the first year after diagnosis averaged $184,000 in the United States, with out-of-pocket expenses for insured patients ranging from $8,000 to $25,000. For uninsured or underinsured patients, those numbers are simply non-negotiable. Even in countries with public health systems — the UK, Canada, Australia — wait times for neurosurgical consultation and surgery can stretch from 4 to 12 weeks. For a grade IV glioma, that delay is clinically meaningful.

Patients end up trapped between two bad options: bankrupting their families or waiting in a queue while the tumor grows.

Why Huashan Hospital Delivers Results for Glioma Patients

Huashan Hospital, affiliated with Fudan University, sits at the top of China’s neurosurgery hierarchy. Its Department of Neurosurgery was founded in 1952 and has been ranked among China’s top 3 neurosurgery departments in the Fudan University Hospital Rankings for over a decade. The department runs 12 specialized wards with more than 600 beds — a scale that dwarfs most Western neurosurgery units.

Surgical Volume Drives Intraoperative Judgment

Volume is not a vanity metric in neurosurgery. A 2020 study in The Lancet Oncology found that hospitals performing more than 50 glioma resections per year had significantly lower 30-day mortality rates than low-volume centers. Huashan’s glioma team operates on over 2,000 glioma cases annually. The average US neurosurgeon performs fewer than 20 glioma resections per year. That gap translates into something tangible: the ability to recognize subtle intraoperative findings, to know when to push for a more complete resection and when to stop to protect language or motor function.

Huashan was also an early adopter of awake craniotomy with intraoperative cortical mapping. The technique allows surgeons to remove tumor tissue while the patient is conscious, responding to verbal cues and movement commands. This maximizes extent of resection — the single strongest predictor of survival in both low-grade and high-grade gliomas — while minimizing permanent neurological deficits.

Technology Without the Waiting List

The hospital operates 11 dedicated neurosurgical operating suites equipped with intraoperative MRI (iMRI), 5-ALA fluorescence-guided resection, and neuronavigation systems. iMRI lets surgeons scan the brain mid-operation to confirm they have removed the entire tumor before closing. 5-ALA makes glioma cells glow under specific light, helping distinguish tumor margins from healthy tissue.

These tools exist at top Western centers too. The difference is access. At Huashan’s international department, a foreign patient can typically secure a surgical slot within 2 to 4 weeks of completing remote evaluation. At leading US and European centers, the same process often takes 6 to 10 weeks.

Cost Advantage Without Quality Compromise

Why is glioma treatment cost at Huashan Hospital so much lower? The answer is structural, not a reflection of lower standards. Chinese hospital systems operate on significantly lower labor costs — a senior neurosurgeon’s annual salary in Shanghai is roughly one-fifth to one-eighth that of a US counterpart. Hospital construction, medical device procurement, and nursing staffing all run at lower price points. But the clinical protocols mirror international guidelines: the same WHO CNS tumor classification, the same NCCN treatment algorithms, the same surgical techniques taught at global neurosurgery conferences.

Prices vary by hospital and case complexity. These figures reflect published international department rates and patient-reported costs from 2024, not quotes for any individual case.

How Glioma Surgery Is Done at Huashan Hospital: Step by Step

If you are asking “how is glioma surgery done at Huashan Hospital,” the answer follows a protocol that will feel familiar to anyone who has researched Western neurosurgical care — with some important differences in logistics.

The process starts with remote review. You send your existing MRI (DICOM format preferred), pathology reports if a biopsy has been done, and a summary of your neurological symptoms. Huashan’s international department reviews these within 3 to 5 business days. If surgery is indicated, you receive a written treatment plan with a cost estimate.

Once you arrive in Shanghai, the pre-operative workup takes 2 to 3 days. This includes a fresh high-resolution MRI (often 3 Tesla with spectroscopy and diffusion tensor imaging), blood work, an ECG, and a consultation with the anesthesiology team. For tumors near language or motor areas, a functional MRI (fMRI) maps those regions so the surgical plan avoids them.

Surgery itself follows one of two paths. For tumors in non-eloquent brain regions, you receive general anesthesia and the procedure takes 3 to 5 hours. For tumors near speech or motor cortex, Huashan’s team performs an awake craniotomy. You are sedated while the skull is opened, then woken for the mapping phase. The neurosurgeon stimulates areas of the brain with a small electrode while you name objects, count, or move your fingers. This identifies critical zones in real time. The tumor removal then proceeds around those zones. Patients report the experience as strange but not painful — the brain itself has no pain receptors.

Post-operative care runs 5 to 10 days in the hospital. A CT or MRI within 48 hours confirms the extent of resection. Pathology and molecular testing take 7 to 14 days. Those results determine whether you need radiation, temozolomide, or — for low-grade tumors with favorable markers — surveillance only.

Can Foreigners Get Glioma Treatment in Shanghai? The Real Answer

Yes — but the route matters. The question “can foreigners get glioma treatment in Shanghai” deserves a precise answer because the Chinese public hospital system does not work like Western systems.

Huashan’s standard public outpatient clinic sees 10,000+ patients per day. You cannot book an appointment from overseas through that channel. You would need to physically queue at the hospital, obtain a medical card, and wait for an available slot — all in Mandarin, all without guaranteed access to a senior neurosurgeon. For a foreign patient with a brain tumor, that route is impractical and risky.

The international department — sometimes called the VIP or Special Medical Service — operates under different rules. It accepts pre-arranged appointments for foreign patients, provides English-speaking coordination staff, and schedules surgery with senior attending neurosurgeons. The cost runs 1.5 to 2 times the standard public rate, which is still dramatically lower than Western pricing. This is the channel we coordinate through for international patients.

What Huashan does not offer is a guarantee of a specific named surgeon on a specific date. The international department will assign you to a senior neurosurgeon from the glioma specialty team, but the exact surgeon depends on scheduling. If you want a specific professor by name, that requires a separate consultation coordination process and may extend your timeline.

Practical Considerations: Records, Visas, and Payment for Glioma Treatment in Shanghai

Before you book a flight, you need four things in order.

First, medical records. Huashan’s international department requires your complete imaging history — ideally the last two MRIs in DICOM format, not just printed films or JPEG screenshots. If you have had a biopsy, the pathology slides or blocks should be sent for re-review. Chinese pathologists will re-confirm the diagnosis and run molecular markers (IDH1/2 mutation, MGMT promoter methylation, 1p/19q codeletion) that determine both prognosis and treatment. Record translation into Chinese is handled by the international department, but you should budget 3 to 5 days for this step.

Second, the visa. Foreign patients traveling to China for medical treatment apply for an S2 visa, which covers short-term private affairs including medical treatment. Your accompanying family members also apply for S2 visas. The hospital provides an invitation letter and treatment confirmation document that you submit with your application. Processing times vary by country — typically 1 to 4 weeks. We always advise patients to apply as soon as the treatment plan is confirmed. The M visa is for commercial and trade activities and does not apply to medical travel.

Third, payment. Huashan’s international department requires a deposit before admission — typically 50% to 70% of the estimated surgery cost. Payment is made by international bank transfer or major credit card. Chinese public hospitals do not bill Western insurance companies directly. You pay upfront and submit claims for reimbursement afterward. If your insurer requires pre-authorization, request the treatment plan and cost estimate from the hospital before you travel and submit those documents to your insurer.

Fourth, language. Even in the international department, not every nurse, technician, or ward staff member speaks fluent English. The coordination office handles scheduling and major consultations in English, but day-to-day ward communication can be challenging. This is where a bilingual medical companion changes the experience — someone who handles registration, translates during rounds, explains medication instructions, and advocates for you when questions arise.

Frequently Asked Questions